Oseltamivir phosphate and Ofloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oseltamivir phosphate (oseltamivir phosphate) and Ofloxacin (ofloxacin). Common drug interactions include ear infection among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Oseltamivir phosphate and Ofloxacin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Oseltamivir phosphate?

Oseltamivir phosphate has active ingredients of oseltamivir phosphate. eHealthMe is studying from 1,825 Oseltamivir phosphate users. Check the latest studies of Oseltamivir phosphate.

What is Ofloxacin?

Ofloxacin has active ingredients of ofloxacin. It is often used in urinary tract infection. eHealthMe is studying from 9,372 Ofloxacin users. Check the latest studies of Ofloxacin.

On Jul, 29, 2026

16 people who take Oseltamivir phosphate and Ofloxacin together, and have interactions are studied.

Oseltamivir phosphate and Ofloxacin drug interactions.

What are the common drug interactions of Oseltamivir Phosphate and Ofloxacin, by gender? *:

female:

Ear infection
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Influenza
Fall
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Face injury
Pleuritic pain
Pulmonary mass
Rib fracture

male:

Cardiac failure
Ejection fraction decreased (systolic heart failure)
Weight decreased
Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)

What are the common drug interactions of Oseltamivir Phosphate and Ofloxacin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cardiac failure
Ejection fraction decreased (systolic heart failure)
Weight decreased

40-49:

n/a

50-59:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)

60+:

Allergy to animal
Allergy to chemicals
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Dizziness
Eye swelling
Fall
Fatigue (feeling of tiredness)
Gastritis (inflammation of stomach)
Headache (pain in head)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 56.25%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 56.25%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 18.75%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
Pneumonia Necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs): 2 people, 12.50%
Pneumonia Staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus): 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 6.25%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 6.25%
Fungal Infection: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Oseltamivir phosphate and Ofloxacin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously